Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis

Arthritis Care and Research

Volumn 67, Issue 7, 2015, Pages 940-946

  Molina, Emily ^a   Del Rincon, Inmaculada ^a   Restrepo, Jose Felix ^a   Battafarano, Daniel F ^b   Escalante, Agustin ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT;

ADULT; AGED; ARTICLE; DAS28; DISEASE ACTIVITY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE ACCESS; HUMAN; INCOME; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; RHEUMATOID ARTHRITIS; SELF REPORT; SOCIAL STATUS; SYMPTOM ASSESSMENT; THERAPY DELAY; ARTHRITIS, RHEUMATOID; DISABLED PERSON; DRUG EFFECTS; ECONOMICS; HEALTH CARE DELIVERY; JOINT; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISABLED PERSONS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; JOINTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84932633475     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22542     Document Type: Article

References (39)

1. Scott D, Wolfe F, Huizinga T., Rheumatoid arthritis. Lancet 2010; 376: 1094-8.
2. Lard LR, Visser H, Speyer I, Vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al., Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001; 111: 446-51.
3. Anderson JJ, Wells G, Verhoeven AC, Felson DT., Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000; 43: 22-9.
4. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS., Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002; 61: 290-7.
5. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS., Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004; 43: 906-14.
6. Furst DE., Window of opportunity. J Rheumatol 2004; 3: 1677-9.
7. O'Dell JR,. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 2002; 46: 283-5.
8. Burska A, Parmar R, El-Sherbiny Y, El Jawhari J, Emery P, Ponchel F., An immunological window of opportunity defines the ability of early RA patients to achieve remission with first anti-rheumatic treatment [abstract]. Ann Rheum Dis 2013; 72 Suppl 1: A14.
9. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, et al., The window of therapeutic opportunity in multiple sclerosis. J Neurology 2006; 253: 98-108.
10. Feldman DE, Bernatsky S, Haggerty J, Leffondre K, Tousignant P, Roy Y, et al., Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study. Arthritis Rheum 2007; 57: 1419-25.
11. Polluste K, Kallikorm R, Meiesaar K, Lember M., Use of general practice and rheumatology outpatient services in rheumatoid arthritis. J Fam Pract 2012; 29: 433-40.
12. Tavares R, Pope JE, Tremblay JL, Thorne C, Bykerk VP, Lazovskis J, et al., Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort. J Rheumatol 2012; 39: 2088-97.
13. Jacobi CE, Mol GD, Boshuizen HC, Rupp I, Dinant HJ, van den Bos GA., Impact of socioeconomic status on the course of rheumatoid arthritis and on related use of health care services. Arthritis Rheum 2003; 49: 567-73.
14. Nemet GF, Bailey AJ., Distance and health care utilization among the rural elderly. Soc Sci Med 2000; 50: 1197-208.
15. Arcury TA, Gesler WM, Preisser JS, Sherman J, Spencer J, Perin J., The effects of geography and spatial behavior on health care utilization among the residents of a rural region. J Health Serv Res 2005; 40: 135-56.
16. Huang B, Dignan M, Han D, Johnson O., Does distance matter? Distance to mammography facilities and stage at diagnosis of breast cancer in Kentucky. J Rur Health 2009; 25: 366-71.
17. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, et al., Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003; 106: 416-22.
18. Jones SE., Metastatic breast cancer: the treatment challenge. Clin Breast Cancer 2008; 8: 224-33.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
20. Escalante A, del Rincon I., How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999; 42: 1712-21.
21. Escalante A, del Rincon I., The disablement process in rheumatoid arthritis. Arthritis Rheum 2002; 47: 333-42.
22. Escalante A, del Rincon I, Mulrow CD., Symptoms of depression and psychological distress among Hispanics with rheumatoid arthritis. Arthritis Care Res 2000; 13: 156-67.
23. Nam CB, Powers MG., The socioeconomic approach to status measurement with a guide to occupational and socioeconomic status scores. Houston (TX): Cap & Gown Press; 1983.
24. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP., Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 1346-53.
25. Orces CH, del Rincon I, Abel MP, Escalante A., The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum 2002; 47: 67-72.
26. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL., Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
27. Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A., Heterogeneity between men and women in the influence of the HLA-DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum 2002; 46: 1480-8.
28. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al., How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985; 28: 1326-35.
29. Gillis JZ, Yazdany J, Trupin L, Julian L, Panopalis P, Criswell LA, et al., Medicaid and access to care among persons with systemic lupus erythematosus. Arthritis Rheum 2007; 57: 601-7.
30. Pedersen M, Jacobsen S, Klarlund M, Frisch M., Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study. J Rheumatol 2006: 33: 1069-74.
31. Begtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L., Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005; 64: 1588-94.
32. Pincus T, Callahan LF., Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chronic Dis 1985; 38: 973-84.
33. Massardo L, Pons-Estel BA, Wojdyla D, Cardiel MH, Galarza-Maldonado CM, Sacnun MP, et al., Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline. Arthritis Care Res (Hoboken) 2012; 64: 1135-43.
34. Brekke M, Hjortdahl P, Thelle DS, Kvien TK., Disease activity and severity in patients with rheumatoid arthritis: relations to socioeconomic inequality. Soc Sci Med 1999; 48: 1743-50.
35. Harrison MJ, Tricker KJ, Davies L, Hassell A, Dawes P, Scott DL, et al., The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol 2005; 32: 2330-6.
36. Aletaha D, Funovits J, Ward MM, Smolen JS, Kvien TK., Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baseline. Arthritis Rheum 2009; 61: 313-20.
37. Wolfe F, Pincus T., Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum 1999; 42: 1797-808.
38. Bruynesteyn K, van der Heijde D, Boers M, Saudan A, Peloso P, Paulus H, et al., Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference. Arthritis Rheum 2002; 46: 913-20.
39. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al., Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-9.